NYSEIndustrialsBuilding Products & EquipmentSnapshot 2026-07-31
Reading BLDR? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Building Products is in recovery. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Achieve 2026 revenue target of $14.6-$15.6 billion: revenue guidance $14.0-$14.8B vs $14.6B target.
View ThesisRevenue is contracting — down about 9% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityMiddle-of-the-pack management execution.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 2% on a typical day and fell roughly 56% in its worst 12-month stretch.
View RiskBLDR must maintain its gross margin between 27.5% and 29% to justify its price. The latest quarter showed a gross margin of 28.3%, which meets this target. It trades at 15× P/E, below the 19× peer median. This suggests that the price reflects less growth than expected. A specific risk is the potential for a guidance cut, which could lower estimates. Peer multiples imply a price about 36% above where it trades; this read is provisional.
Trailing returns as of 2026-07-31. BLDR is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 22 analysts currently covering BLDR (as of Jul 2026).
Based on 12 Wall Street analysts offering 12-month price targets for BLDR in the last 4 months.
A consensus fair price across 11 valuation methods, at three horizons. As of 2026-08-01. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Building Products — fair value, gap to price, and forward P/E.
Board resignation raises governance concerns impacting execution.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-07-31. EPS is implied from price ÷ P/E. Not investment advice.
Current $66.44
The last 12 months of price, then the range of analyst 12-month targets from today’s $66.44.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
ESOP moves could enhance margins amid challenges.
Leadership shift aims to improve execution risk.
Stock plummet indicates market concerns affecting valuation.
New HR chief supports execution and operational focus.
Poor earnings indicate potential challenges to revenue targets.
